SOUTH SAN FRANCISCO, Calif., Nov. 15, 2021 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today announced plans to exit early-stage research and focus resources on its mid to late-stage ...

SOUTH SAN FRANCISCO, Calif., Aug. 21, 2020 /PRNewswire/ -- Rigel Pharmaceuticals (Nasdaq: RIGL) today announced that it has granted awards pursuant to the Rigel Pharmaceuticals, Inc. Inducement Plan, ...

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and ...

SOUTH SAN FRANCISCO, Calif., Dec. 15, 2017 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the resignation of Ryan Maynard, executive vice president and chief financial ...

Shares of Rigel Pharmaceuticals jumped more than 15% as the biotech company announced an exclusive $960 million collaboration with Eli Lilly to develop and commercialize receptor interacting ...

NEW YORK (CBS.MW) -- The IPO road for Rigel Pharmaceuticals has definitely been rocky. The company filed its offering in February 2000. Several months later, the IPO was withdrawn. Then the company re ...

Rigel Medical has supplied medical test equipment to a global charity which delivers healthcare services onboard the world’s largest private hospital ship. The company, which is based in the North ...

Rigel Pharmaceuticals Inc. (Nasdaq: RIGL) today announced that it has initiated a Phase 2 clinical trial to evaluate fostamatinib, its oral SYK inhibitor, as a potential treatment for autoimmune ...